About Cancilico

At Cancilico, we use artificial intelligence and computer vision to shape the cancer diagnostics and therapy of tomorrow. Building upon our multidisciplinary expertise in computer science and clinical medicine, we provide a versatile product suite for the detection of blood disorders in microscopy. This enables us to substantially improve diagnostics in clinical routine and as part of clinical trials. Furthermore, we can identify relevant mutations and target structures for the development of digital biomarkers. Additionally, we help healthcare and pharmaceutical corporations to shape their AI portfolio by developing custom-made models for cancer detection and treatment tailored to the needs of your company.